Clinical characteristics, therapeutic outcomes of isolated atypical optic neuritis in China

[1]  L. Bielory,et al.  Clinical characteristics, diagnostic criteria and therapeutic outcomes in autoimmune optic neuropathy , 2009, British Journal of Ophthalmology.

[2]  B. Weinshenker,et al.  NMO-IgG predicts the outcome of recurrent optic neuritis , 2008, Neurology.

[3]  Melvin Greer,et al.  Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up. , 2008, Archives of neurology.

[4]  J. LeLorier,et al.  Clinical consequences of generic substitution of lamotrigine for patients with epilepsy , 2008, Neurology.

[5]  Gordon T Plant,et al.  Optic neuritis and multiple sclerosis , 2008, Current opinion in neurology.

[6]  P. Vermersch,et al.  NMO-IgG and Devic's neuromyelitis optica: a French experience , 2008, Multiple sclerosis.

[7]  G. Plant,et al.  Optic Neuritis: An Update Typical and Atypical Optic Neuritis , 2008 .

[8]  Marco Rovaris,et al.  MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study , 2007, The Lancet Neurology.

[9]  B. Weinshenker,et al.  Revised diagnostic criteria for neuromyelitis optica , 2006, Neurology.

[10]  Ichiro Nakashima,et al.  A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis , 2004, The Lancet.

[11]  G. Plant,et al.  Chronic relapsing inflammatory optic neuropathy (CRION). , 2003, Brain : a journal of neurology.

[12]  D. Miller,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Management of Acute Optic Neuritis , 2022 .

[13]  R. Burde,et al.  Autoimmune optic neuropathy: evaluation and treatment. , 1988, Journal of neurology, neurosurgery, and psychiatry.